In pharmaceuticals, the most valuable thing a company can sell, beyond efficacy, beyond convenience, is trust. But trust, as it turns out, doesn’t come with a logo. It’s not printed on the label or embedded in the capsule. It’s built, layer by layer, through systems.
Systems that trace every product unit from origin to destination. Systems that speak the same language across countries, warehouses, vendors, and regulators. Systems that can answer the question every patient silently asks when they pick up a prescription: Is this real?
The scale of the problem isn’t hypothetical. According to a report, counterfeit medicines account for approximately 10% of global pharmaceutical sales. In developing markets, that figure can be significantly higher. It is not just a revenue leak, it’s a crisis of confidence. A weak serialization system doesn’t just threaten compliance. It fractures the chain of custody. And when that chain breaks, so does the promise that the product in the box matches the science on the label.
In an effort to tighten the promise, the U.S. government passed the Drug Supply Chain Security Act (DSCSA). By 2024, all pharmaceutical products distributed in the U.S. are supposed to be serialized on the unit level and traceable at any time across the supply chain. This means that anything and everything from bottles, blister packs, to cartons will require a unique, standards-approved identifier that can instantly be validated anywhere on its journey.
For global pharma manufacturers, this wasn’t just another IT upgrade; it was a structural reset.
One of the world’s largest pharmaceutical organizations was tasked with achieving full DSCSA compliance across all U.S. operations. This task required maintaining existing operations, timelines, and relationships with external partners. The existing landscape was complex. The legacy systems were effective at managing inventory and logistics internally. However, they were not designed to support unit-level serialization and traceability in real time or EPCIS (Electronic Product Code Information Services) standards.
That’s where the work began. The company formed a cross-functional team of experts, compliance professionals, SAP architects, warehouse managers, and serialization analysts to lead the transformation. Among them was Sampath Kumar Mucherla, a seasoned SAP Consultant with 20+ years of experience in ERP architecture, system integration, and warehouse execution strategies. With deep domain exposure in consumer electronics, insurance, and manufacturing, and with hands-on SAP EWM and ATTP experience, he brought both technical clarity and domain fluency to the table.
But this wasn’t a one-person job. It couldn’t be. The project touched everything: data governance, partner integration, test automation, master data integrity, and real-time reporting. It required alignment across global manufacturing plants, 3PL vendors, packaging lines, and downstream distributors.
The first issue wasn’t technical. It was definitional. How do you define “trusted data” when identifiers vary by partner? When some systems track lots, others track batches, and some treat serial numbers as optional metadata? When is master data duplicated or misaligned across business units?
That is where standardization came in. Sampath and his team implemented a data model. The model aligned with GS1 standards, defining rules for Global Trade Item Numbers (GTINs), serialized product identifiers, and Global Location Numbers (GLNs). This wasn’t just a back-end cleanup. It was a foundational step that enabled automated error detection and real-time validation at every point in the chain.
Sampath played a key role in this effort. He designed onboarding workflows for external partners. His experience in ERP and warehouse execution made these workflows easy to comply with, even for partners with varied systems. GLN and GTIN validations were embedded at the source. SAP ATTP was integrated not just with SAP ECC and EWM modules, but with partner systems via EPCIS protocols. Data that once had to be manually cleaned post-facto was now validated at the moment of creation.
What followed was a transformation not just in software, but in manufacturing floor dynamics. SAP ATTP was connected directly to packaging lines, scanners, printers, and controllers, allowing real-time assignment and verification of unique barcodes. By implementing hybrid serial generation logic and late aggregation scanning mechanisms, Sampath’s team ensured high-speed packaging wasn’t slowed, even on lines pushing 300 bottles per minute.
This new serialization landscape was tested rigorously. Earlier, performance testing would take two full days, often plagued by mismatched data, incomplete mappings, and long feedback loops. After the system redesign, test cycles were reduced to just a few hours. Rework dropped dramatically. Partners who earlier took weeks to onboard were now fully integrated within days.
The most important shift wasn’t in speed. It was in control. The company could now see serialization errors before they reached a production environment. Teams across geographies were empowered to detect and resolve anomalies independently. Traceability, once reactive, became proactive. This, in turn, changed the company’s posture toward compliance. Instead of being a burden, serialization became a strategic advantage.
When a regulator requested product movement data, the system responded immediately with clean, auditable histories. When a recall situation emerged, the team could isolate affected batches and track their movement within hours, not days. Inventory visibility improved. Shipment discrepancies dropped. Revenue leakage from stockouts and misrouted shipments was mitigated.
Behind this was not just a new SAP configuration, but a culture of systems thinking. In Sampath’s words, “Serialization isn’t just about barcodes. It’s about visibility. It gives us the ability to see not just where the product is, but where the process breaks down.” That ability has far-reaching implications.
With serialization in place, new doors opened. Data from SAP ATTP became the basis for advanced analytics. Forecasting tools were developed to identify supply bottlenecks before they hit fulfillment. Teams began exploring blockchain integrations for immutable data sharing across borders. Conversations about digital twins, systems that mirror the physical supply chain in real time, moved from whiteboards into pilot phases.
The evolution is ongoing. Today, Sampath Kumar Mucherla and his team continue to refine the architecture. They are exploring how artificial intelligence and machine learning can predict noncompliance risks. The long-term vision? A fully adaptive serialization ecosystem; resilient, intelligent, and scalable across global markets.
None of this is glamorous. And that’s the point. Serialization success stories don’t usually make headlines. There’s no “product launch moment,” no viral announcement. But what they do create is infrastructure. Quietly, steadily, they build the kind of systems that make high-stakes industries like pharma trustworthy. And trust, once earned through systems that work reliably, becomes a business asset, one that compounds over time.
At the core of this transformation is not a hero, but a principle: systems, when designed with intention and precision, can carry a promise farther than any individual ever could. That promise, that the product in the box is what it claims to be, might just be the most valuable thing a company can deliver.